Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

Peter's takeaways on liver health, heart rate variability, AI in medicine & more (PS 2 sneak peek)

View show notes here: https://bit.ly/3B3PNOk Become a member to receive exclusive content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ In this quarterly podcast summary (QPS) episode, Peter summarizes his biggest takeaways from the last three months of guest interviews on the podcast. Peter shares key insights from each episode, covering diverse topics such as liver health with Julia Wattacheril, heart rate variability with Joel Jamieson, artificial intelligence with Zak Kohane, klotho for brain health with Dena Dubal, and lactate and lactate metabolism with George Brooks. Additionally, Peter shares any personal behavioral adjustments or modifications to his patient care practices that have arisen from these engaging discussions. We discuss: 00:00 - Intro 00:10 - Overview of topics, and the positive feedback on the quarterly podcast summary format 02:28 - Julia Wattacheril episode: liver health and disease 15:27 - Noninvasive methods to diagnose liver conditions, and how to manage and improve liver health In the full episode, we also discuss: -Joel Jamieson episode: heart rate variability (HRV) for training and health; -Practical tools for measuring HRV and how it informs training and recovery decisions; -Zak Kohane episode: artificial intelligence and medicine; -The current role of AI in medicine and how it could revolutionize medicine in the future; -The limitations and concerns pertaining to AI; -Dena Dubal episode: the potential benefits of klotho for brain health; -Animal studies on klotho and brain health; -Genetics-based variations in klotho levels in humans and their impact on cognition, disease risk, and longevity; -Testing klotho levels, the significance of the KL-VS variant, the role of exercise in increasing klotho, and more; -The potential of klotho as a treatment for cognitive decline and Alzheimer's disease; -George Brooks episode: a new paradigm to think about lactate and lactate metabolism; -The potential for lactate infusions to aid in brain recovery following a head injury; -The relationship between lactate and cancer, and the impact of exercise on lactate levels and cancer risk; and -More. -------- About: The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more. Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. Learn more: https://peterattiamd.com Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

Peter Attiahost
Sep 30, 202427mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

Peter Attia recaps liver health, MASLD diagnosis and management in quarterly summary

  1. The episode is the second quarterly podcast summary, a format that drew very positive listener feedback and will now be a regular feature.
  2. Attia explains the liver's uniqueness: it has no extracorporeal support, and its metabolism, protein synthesis, and detoxification functions have no parallel.
  3. He covers the shift from NAFLD to MASLD, noting that per Julia Wattacheril 99.6 percent of people meeting NAFLD criteria also meet MASLD criteria, and that MASLD is now the leading cause of steatosis and fibrosis.
  4. On diagnosis, he explains that ALT and AST are poor tests for MASLD and that imaging such as MR elastography with PDFF or FibroScan better quantifies fat and fibrosis.
  5. Management centers on weight loss, improved insulin sensitivity, and removing alcohol and liquid fructose, sometimes with GLP-1 agonists, since no drug is clearly indicated.

IDEAS WORTH REMEMBERING

5 ideas

The liver cannot be supported outside the body

Unlike kidneys, lungs, or the heart, liver failure has no dialysis or ventilator equivalent, so transplant is the only solution, reflecting the organ's complex functions.

Drink sizes are larger than people think

A standard drink has about 14 to 15 grams of ethanol, found in 12 ounces of regular beer, 5 ounces of wine, or 1.5 ounces of liquor. Attia notes his own wine pours are closer to 8 ounces.

MASLD and NAFLD nearly overlap

MASLD requires metabolic dysfunction such as insulin resistance and at least 5 percent of hepatocytes containing fat. Attia says the distinction hardly matters to listeners given the near-total overlap.

Waiting for elevated transaminases may wait too long

In adults, fibrosis and steatosis occur near the central vein, delaying enzyme elevation, so disease can progress for a while before ALT and AST rise.

Liver cancer risk rises with scarring, except in hep B

For MASLD, alcoholic liver disease, and hep C, cancer risk climbs with fibrosis, while hep B carries roughly a 3 to 5 percent yearly risk regardless of disease stage.

WORDS WORTH SAVING

5 quotes

you just don't expect to turn on a podcast and walk into a graduate level seminar on the liver. But if you take a step back and think about it, we kind of need to, right? It is arguably one of the most important organs in the body.

— Peter Attia

if your kidneys fail, God forbid, that's very bad, but at least you have the option of dialysis. If your lungs fail, again, not a good thing, but at least you have a ventilator.

— Peter Attia

If a person goes into liver failure, their only solution is a liver transplant.

— Peter Attia

This is something that is going to respond most favorably to a reduction in excess adipose tissue and an improvement in insulin sensitivity.

— Peter Attia

it is simple but not easy, right? Simple in concept, can be challenging in practice

— Peter Attia

Quarterly podcast summary formatLiver function and lack of extracorporeal supportAlcohol metabolism and standard drink sizesNAFLD vs MASLD terminologyHepatitis B and C and cancer riskALT and AST limitationsFibroScan and MR elastography

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.